These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3486754)

  • 21. Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography.
    Foulstone M; Reading C
    Antimicrob Agents Chemother; 1982 Nov; 22(5):753-62. PubMed ID: 7181486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three day oral course of Augmentin to treat chancroid.
    Ndinya-Achola JO; Nsanze H; Karasira P; Fransen L; D'Costa LJ; Piot P; Ronald AR
    Genitourin Med; 1986 Jun; 62(3):202-4. PubMed ID: 3733082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP; Phutane L; Patel MH; Rupwate RU; Kamat SR
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
    Houang ET; Colley N; Chapman M
    Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB; Casey PA; Cooper DL
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children.
    van Niekerk CH; van den Ende J; Hundt HK; Louw EA
    Eur J Clin Pharmacol; 1985; 29(2):235-9. PubMed ID: 3908124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single dose treatment of gonococcal urethritis with augmentin in Ibadan.
    Osoba AO; Oyelese AO; Ashiru JO; Ekweozor CC; Ochei J
    Afr J Med Med Sci; 1985; 14(3-4):169-73. PubMed ID: 3004176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.
    Adam D; Heilmann HD; Weismeier K
    Antimicrob Agents Chemother; 1987 Jun; 31(6):935-9. PubMed ID: 3619427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S; Sugita R; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
    Robinson OP
    Antibiot Khimioter; 1992 Sep; 37(9):20-3. PubMed ID: 1444662
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
    Novelli A; Reali EF; Fallani S; Periti P
    Drugs Exp Clin Res; 1989; 15(4):151-4. PubMed ID: 2505995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
    Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
    Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
    Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of 'Augmentin' in lower respiratory tract infections: pharmacokinetic and clinical results.
    Havard CW; Fernando A; Brumfitt W; Hamilton-Miller JM
    Br J Dis Chest; 1982 Jul; 76(3):255-60. PubMed ID: 6751365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.